内镜检查前风险评分对急诊上消化道出血患者不良结局的预测价值:一项系统评价
该系统评价检索 MEDLINE、PubMed、Embase 和 Cochrane 系统评价数据库(自建库至2015年3月),纳入16项研究,评估成人急诊上消化道出血患者内镜前风险评分对30天严重不良事件(30天死亡、再出血和需干预的复合结局)的预测价值。GBS 总体敏感性0.98、特异性0.16;cRockall 分别为0.93和0.24;AIMS65 分别为0.79和0.61。GBS 以0分为界值时敏感性0.99、特异性0.08。作者结论认为,GBS 0分在识别低危患者方面优于其他界值和其他评分,但特异性很低;所评价的风险评分均不够稳健,不能推荐用于临床实践,需要未来前瞻性研究开发稳健的新评分。
要点
- GBS 以0分为界值识别低危患者敏感性0.99、特异性0.08,敏感性高但特异性很低。
- GBS 总体敏感性0.98、特异性0.16;cRockall 敏感性0.93、特异性0.24;AIMS65 敏感性0.79、特异性0.61。
- 复合结局为30天死亡、再出血和需干预,系统评价共纳入16项研究。
- 作者结论:所评价的内镜前风险评分均不够稳健,不能推荐用于临床实践。
- 作者提出需要未来前瞻性研究开发用于急诊上消化道出血患者的稳健新评分。
适用人群与场景
- 成人急诊上消化道出血患者。
- 排除综述、病例报告和动物研究。
研究设计与关键结果
- 系统评价共检索到3173篇文章,最终纳入16项研究:3项研究GBS,1项研究cRockall,2项研究AIMS65,6项比较GBS与cRockall,3项比较GBS、GBS的一种改良版本与cRockall,1项比较GBS与AIMS65。
- 复合结局包括30天死亡、再出血和需干预。
- GBS 总体敏感性0.98、特异性0.16;cRockall 敏感性0.93、特异性0.24;AIMS65 敏感性0.79、特异性0.61。
- GBS 以0分为界值时敏感性0.99、特异性0.08。
- 作者结论:GBS 0分在识别低危患者方面优于其他界值和其他风险评分,但特异性很低。
证据类型、等级与局限
- 证据类型:系统评价。
- 作者结论:所评价的风险评分均不够稳健,不能推荐用于临床实践。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为所评价的内镜前风险评分均不够稳健,不能推荐用于临床实践,急诊医生据此不能将这些评分作为处置决策的稳健依据。
- 作者提出需要未来前瞻性研究开发用于急诊上消化道出血患者的稳健新评分。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Risk stratification of emergency department (ED) patients with upper gastrointestinal bleeding (UGIB) using preendoscopic risk scores can aid ED physicians in disposition decision-making. We conducted a systematic review to assess the predictive value of preendoscopic risk scores for 30-day serious adverse events.
METHODS: We searched MEDLINE, PubMed, Embase, and the Cochrane Database of Systematic Reviews from inception to March 2015. We included studies involving adult ED UGIB patients evaluating preendoscopic risk scores and excluded reviews, case reports, and animal studies. The composite outcome included 30-day mortality, recurrent bleeding, and need for intervention. In two phases (screening and full review), two reviewers independently screened articles for inclusion and extracted patient-level data. The consensus data were used for analysis. We reported sensitivity, specificity, positive and negative predictive value, and positive and negative likelihood ratios with 95% confidence intervals.
RESULTS: We identified 3,173 articles, of which 16 were included: three studied Glasgow Blatchford score (GBS); one studied clinical Rockall score (cRockall); two studied AIMS65; six compared GBS and cRockall; three compared GBS, a modification of the GBS, and cRockall; and one compared the GBS and AIMS65. Overall, the sensitivity and specificity of the GBS were 0.98 and 0.16, respectively; for the cRockall they were 0.93 and 0.24, respectively; and for the AIMS65 they were 0.79 and 0.61, respectively. The GBS with a cutoff point of 0 had a sensitivity of 0.99 and a specificity of 0.08.
CONCLUSION: The GBS with a cutoff point of 0 was superior over other cutoff points and risk scores for identifying low-risk patients but had a very low specificity. None of the risk scores identified by our systematic review were robust and, hence, cannot be recommended for use in clinical practice. Future prospective studies are needed to develop robust new scores for use in ED patients with UGIB.
参考来源
- Ramaekers R, Mukarram M, Smith CA, et al. The Predictive Value of Preendoscopic Risk Scores to Predict Adverse Outcomes in Emergency Department Patients With Upper Gastrointestinal Bleeding: A Systematic Review. Acad Emerg Med. 2016. PMID: 27640399. doi:10.1111/acem.13101
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。